Rocket One Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Net Income -$13.3MTTM through 30 Jun 2026
Free Cash Flow -$10.7MTTM through 30 Jun 2026
Margins
| Current |
|---|
Returns
-162.4%ROE
-139.0%ROA
Balance Sheet Health
Current Ratio6.20x
Cash & Equivalents$7.9M
Quality Metrics
Piotroski F-Score3 / 9
Earnings-Beat Rate25.0%
Multi-Year Trend
Diluted EPS-$0.82TTMFY2025: $-0.90
Dividend
No dividend
Capital Allocation
R&D Spend$6.4M
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Developing new generation therapies for unmet medical needs | $0 | View detailsLegacy biotechnology programs will continue to be advanced under a wholly owned subsidiary, Rocket One 2.0 Inc. | |
| Orbital Economy and AI Semiconductor Infrastructure | $0 | View detailsRepositioning around next-generation nanomagnetic AI chip technology designed for radiation-tolerant, energy-constrained environments in space and defense applications. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.